Pharmaron Beijing Statistics

Total Valuation

HKG:3759 has a market cap or net worth of HKD 40.33 billion. The enterprise value is 44.07 billion.

Market Cap	40.33B
Enterprise Value	44.07B

Important Dates

The last earnings date was Thursday, March 27, 2025.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	Jun 27, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.11%
Shares Change (QoQ)	+0.32%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.21B

Valuation Ratios

The trailing PE ratio is 21.13.

PE Ratio	21.13
Forward PE	n/a
PS Ratio	3.09
PB Ratio	2.66
P/TBV Ratio	3.76
P/FCF Ratio	70.70
P/OCF Ratio	14.71
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.03, with an EV/FCF ratio of 77.26.

EV / Earnings	23.09
EV / Sales	3.37
EV / EBITDA	15.03
EV / EBIT	24.07
EV / FCF	77.26

Financial Position

The company has a current ratio of 1.80, with a Debt / Equity ratio of 0.42.

Current Ratio	1.80
Quick Ratio	1.44
Debt / Equity	0.42
Debt / EBITDA	2.17
Debt / FCF	11.15
Interest Coverage	7.05

Financial Efficiency

Return on equity (ROE) is 12.48% and return on invested capital (ROIC) is 4.98%.

Return on Equity (ROE)	12.48%
Return on Assets (ROA)	4.26%
Return on Invested Capital (ROIC)	4.98%
Return on Capital Employed (ROCE)	8.73%
Revenue Per Employee	611,303
Profits Per Employee	89,304
Employee Count	21,370
Asset Turnover	0.49
Inventory Turnover	7.60

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +55.56% in the last 52 weeks. The beta is 1.08, so HKG:3759's price volatility has been similar to the market average.

Beta (5Y)	1.08
52-Week Price Change	+55.56%
50-Day Moving Average	15.36
200-Day Moving Average	13.15
Relative Strength Index (RSI)	48.02
Average Volume (20 Days)	11,082,255

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:3759 had revenue of HKD 13.06 billion and earned 1.91 billion in profits. Earnings per share was 1.08.

Revenue	13.06B
Gross Profit	4.45B
Operating Income	1.83B
Pretax Income	2.23B
Net Income	1.91B
EBITDA	2.75B
EBIT	1.83B
Earnings Per Share (EPS)	1.08

Full Income Statement

Balance Sheet

The company has 3.26 billion in cash and 6.36 billion in debt, giving a net cash position of -3.09 billion.

Cash & Cash Equivalents	3.26B
Total Debt	6.36B
Net Cash	-3.09B
Net Cash Per Share	n/a
Equity (Book Value)	15.14B
Book Value Per Share	8.21
Working Capital	3.60B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.74 billion and capital expenditures -2.17 billion, giving a free cash flow of 570.41 million.

Operating Cash Flow	2.74B
Capital Expenditures	-2.17B
Free Cash Flow	570.41M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 34.09%, with operating and profit margins of 14.01% and 14.61%.

Gross Margin	34.09%
Operating Margin	14.01%
Pretax Margin	17.04%
Profit Margin	14.61%
EBITDA Margin	21.04%
EBIT Margin	14.01%
FCF Margin	4.37%

Dividends & Yields

This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 1.68%.

Dividend Per Share	0.22
Dividend Yield	1.68%
Dividend Growth (YoY)	-33.08%
Years of Dividend Growth	n/a
Payout Ratio	30.24%
Buyback Yield	0.11%
Shareholder Yield	1.79%
Earnings Yield	4.73%
FCF Yield	1.41%

Dividend Details

Stock Splits

The last stock split was on July 18, 2023. It was a forward split with a ratio of 1.5.

Last Split Date	Jul 18, 2023
Split Type	Forward
Split Ratio	1.5

Scores

HKG:3759 has an Altman Z-Score of 3.66.

Altman Z-Score	3.66
Piotroski F-Score	n/a